☆ 4.6 Article

Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort

MOVEMENT DISORDERS (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies

Ilaria Poggiolini et al.

Summary: The study aimed to assess the diagnostic value of CSF alpha-synuclein RT-QuIC quantitative parameters in regard to disease progression, stratification, and conversion in synucleinopathies. The results showed that alpha-synuclein RT-QuIC adds value in diagnosing Parkinson's disease and may provide a way to distinguish variations within Parkinson's disease phenotype. The assay also showed potential as an early biomarker detecting synucleinopathy in idiopathic REM sleep behaviour disorder patients prior to conversion.

BRAIN (2022)

Add to Collection

Article Clinical Neurology

Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy

Mingyue Luan et al.

Summary: This study evaluated the diagnostic value of salivary alpha-synuclein seeding activity in patients with Parkinson's disease (PD) and multiple system atrophy (MSA). The results suggest that salivary alpha-synuclein seeding activity may serve as a novel biomarker for the clinical diagnosis of PD and MSA.

MOVEMENT DISORDERS (2022)

Add to Collection

Review Clinical Neurology

The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy

Gregor K. Wenning et al.

Summary: This study aims to develop novel diagnostic criteria for multiple system atrophy (MSA) using an evidence-based and consensus-based methodology to improve the diagnostic accuracy, particularly in early disease stages. The criteria were developed and optimized through systematic literature review, Delphi rounds, and a virtual Consensus Conference. Different clinical diagnostic categories were defined, and a new concept of possible prodromal MSA was introduced. Brain magnetic resonance imaging markers were required for the diagnosis of clinically established MSA.

MOVEMENT DISORDERS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Interplay between tau and α-synuclein liquid-liquid phase separation

Anna Siegert et al.

Summary: In patients with Parkinson's disease and dementia, interactions between tau protein pathology and alpha-synuclein pathology may have synergistic effects, contributing to a worse prognosis. Understanding the mechanisms of this interaction can help clarify the relationship between these two distinct pathologies.

PROTEIN SCIENCE (2021)

Add to Collection

Article Clinical Neurology

A rapid α-synuclein seed assay of Parkinson's disease CSF panel shows high diagnostic accuracy

Christina D. Orru et al.

Summary: The study shows that an improved assay for diagnosing Parkinson's disease dramatically reduces the diagnosis time while maintaining high performance standards. Positive signals were found in 97% of Parkinson's disease cases compared to only 13% of healthy controls, with weak correlations between assay parameters and clinical measures observed. The assay's efficiency in diagnosing Parkinson's disease is supported by these findings.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study

Alex Iranzo et al.

Summary: The study found that RT-QuIC can detect misfolded alpha-synuclein in the CSF of patients with IRBD with both high sensitivity and specificity, indicating that detection of alpha-synuclein may serve as an early marker for Parkinson's disease and dementia with Lewy bodies.

LANCET NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure

Wolfgang Singer et al.

Summary: NfL levels at baseline were only elevated in patients who later converted to MSA, perfectly distinguishing them from future PD and DLB converters as well as non-converters. ASyn-PMCA was positive in almost all cases, with marked differences in reaction kinetics seen in samples from patients who later developed MSA. This finding has important implications for prognostication and differentiation of MSA from other synucleinopathies before motor symptoms appear.

ANNALS OF NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder

Ambra Stefani et al.

Summary: RT-QuIC detection of alpha-synuclein aggregates in olfactory mucosa showed a linkage between alpha-synuclein pathology and olfactory dysfunction in patients with isolated RBD and Parkinson's disease, indicating a potential for early detection and preventive therapies.

BRAIN (2021)

Add to Collection

Article Neurosciences

High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease

Marco J. Russo et al.

Summary: Alpha Synuclein seed amplification assays (Alpha Syn-SAAs) are considered promising diagnostic tools for Parkinson's disease and related synucleinopathies, showing high diagnostic accuracy in multiple patient cohorts. This study compared results from three independent laboratories and found high reproducibility and diagnostic performance of the assay.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Add to Collection

Article Neurosciences

Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies

Connor Bargar et al.

Summary: The development of a streamlined RT-QuIC assay based on commercial reagents allows for uniform analysis of alpha Syn(D) in various biospecimens from PD and DLB cases, achieving high sensitivity and specificity in detecting disease-associated aggregates. The use of this assay can improve diagnostic applications and facilitate efficient utilization of scarce biospecimens for understanding disease pathogenesis and monitoring therapeutic efficacies.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Add to Collection

Letter Clinical Neurology

Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression

Luis Concha-Marambio et al.

MOVEMENT DISORDERS (2021)

Add to Collection

Article Multidisciplinary Sciences

Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy

Mohammad Shahnawaz et al.

NATURE (2020)

Add to Collection

Article Clinical Neurology

Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies

Marcello Rossi et al.

ACTA NEUROPATHOLOGICA (2020)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0

Silvia Morbelli et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Add to Collection

Review Biochemistry & Molecular Biology

α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis

Surabhi Mehra et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2019)

Add to Collection

Article Clinical Neurology

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study

Ronald B. Postuma et al.

BRAIN (2019)

Add to Collection

Article Neurosciences

Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders

Sireesha Manne et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2019)

Add to Collection

Article Clinical Neurology

Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease

Un Jung Kang et al.

MOVEMENT DISORDERS (2019)

Add to Collection

Review Clinical Neurology

Idiopathic REM sleep behaviour disorder and neurodegeneration - an update

Birgit Hoegl et al.

NATURE REVIEWS NEUROLOGY (2018)

Add to Collection

Review Cell Biology

The concept of alpha-synuclein as a prion-like protein: ten years after

Jennifer A. Steiner et al.

CELL AND TISSUE RESEARCH (2018)

Add to Collection

Article Neurosciences

Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC

Bradley R. Groveman et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)

Add to Collection

Article Clinical Neurology

Importance of low diagnostic Accuracy for early Parkinson's disease

Thomas G. Beach et al.

MOVEMENT DISORDERS (2018)

Add to Collection

Review Clinical Neurology

Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

Ian G. McKeith et al.

NEUROLOGY (2017)

Add to Collection

Article Clinical Neurology

Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid

Mohammad Shahnawaz et al.

JAMA NEUROLOGY (2017)

Add to Collection

Article Clinical Neurology

Monitoring of 30 marker candidates in early Parkinson disease as progression markers

Brit Mollenhauer et al.

NEUROLOGY (2016)

Add to Collection

Review Clinical Neurology

Accuracy of clinical diagnosis of Parkinson disease A systematic review and meta-analysis

Giovanni Rizzo et al.

NEUROLOGY (2016)

Add to Collection

Article Clinical Neurology

Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies

Graham Fairfoul et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)

Add to Collection

Article Clinical Neurology

Prediagnostic presentations of Parkinson's disease in primary care: a case-control study

Anette Schrag et al.

LANCET NEUROLOGY (2015)

Add to Collection

Article Chemistry, Multidisciplinary

Strong interactions with polyethylenimine-coated human serum albumin nanoparticles (PEI-HSA NPs) alter α-synuclein conformation and aggregation kinetics

Hossein Mohammad-Beigi et al.

NANOSCALE (2015)

Add to Collection

Article Medicine, General & Internal

Imaging insights into basal ganglia function, Parkinson's disease, and dystonia

A. Jon Stoessl et al.

LANCET (2014)

Add to Collection

Article Multidisciplinary Sciences

Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174 Patients

Alex Iranzo et al.

PLOS ONE (2014)

Add to Collection

Article Clinical Neurology

Disease duration and the integrity of the nigrostriatal system in Parkinson's disease

Jeffrey H. Kordower et al.

BRAIN (2013)

Add to Collection

Article Clinical Neurology

Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study

Alex Iranzo et al.

LANCET NEUROLOGY (2013)

Add to Collection

Article Clinical Neurology

Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort

Brit Mollenhauer et al.

NEUROLOGY (2013)

Add to Collection

Article Clinical Neurology

Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series

Carlos H. Schenck et al.

SLEEP MEDICINE (2013)

Add to Collection

Article Clinical Neurology

Incidence and Pathology of Synucleinopathies and Tauopathies Related to Parkinsonism

Rodolfo Savica et al.

JAMA NEUROLOGY (2013)

Add to Collection

Article Clinical Neurology

Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results

Christopher G. Goetz et al.

MOVEMENT DISORDERS (2008)

Add to Collection

Article Clinical Neurology

International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study

Kallol Ray Chaudhuri et al.

MOVEMENT DISORDERS (2006)

Add to Collection

Article Geriatrics & Gerontology

The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment

ZS Nasreddine et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.